NASDAQ:UNCY

Unicycive Therapeutics Stock Forecast

etoro logo Buy UNCY
*Your capital is at risk
$6.92
-0.510 (-6.86%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of UNCY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add UNCY to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Unicycive Therapeutics, Inc. stock price took a fall of -6.86% on Friday
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 02, 2026 Loss -4.29%

The Unicycive Therapeutics, Inc. stock price fell by -6.86% on the last day (Friday, 5th Jun 2026) from $7.43 to $6.92. During the last trading day the stock fluctuated 8.02% from a day low at $6.86 to a day high of $7.41. The price has been going up and down for this period, and there has been a -9.31% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -664 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $7.01. A reaction back to this level may hold a second chance to get out before further falls.

UNCY Signals & Forecast

There are few to no technical positive signals at the moment. The Unicycive Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.25 and $7.62. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -6.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Unicycive Therapeutics, Inc. stock

Unicycive Therapeutics, Inc. finds support from accumulated volume at $6.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.550 between high and low, or 8.02%. For the last week the stock has had daily average volatility of 6.97%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UNCY) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Unicycive Therapeutics, Inc. to open at $7.06, and during the day (based on 14 day Average True Range), to move between $6.68 and $7.16, which gives a possible trading interval of +/-$0.484 (+/-7.25%) up or down from last closing price. If Unicycive Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.06 (2.02%) than the support at $6.68 (3.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Unicycive Therapeutics, Inc. stock A Buy?

The Unicycive Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Unicycive Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.369 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $7.06 ( 2.07%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

UNCY Performance

Trading levels for UNCY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.61 10.02%
R2 7.40 6.98%
R1 7.27 5.11%
Price 6.92
S1 6.85 -0.96%
S2 6.72 -2.84%
S3 6.51 -5.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.08 16.76%
R2 7.43 7.37%
R1 7.06 2.02%
Price 6.92
S1 6.68 -3.47%
S2 6.62 -4.34%
S3 6.39 -7.66%

FAQ

What is the symbol for Unicycive Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Unicycive Therapeutics, Inc. is UNCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Unicycive Therapeutics, Inc. Stock?
The Unicycive Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Unicycive Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Unicycive Therapeutics, Inc. Stock?
Unicycive Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Unicycive Therapeutics, Inc. Stock.

What's the current price of Unicycive Therapeutics, Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Unicycive Therapeutics, Inc. (UNCY) share was $6.92.

What is the 52-week high and low for Unicycive Therapeutics, Inc. Stock?
The 52-week high for Unicycive Therapeutics, Inc. Stock is $8.74 and the 52-week low is $0.470.

What is the market capitalization of Unicycive Therapeutics, Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Unicycive Therapeutics, Inc. is 148.72M.

When is the next earnings date for Unicycive Therapeutics, Inc.?
The upcoming earnings date for Unicycive Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT UNICYCIVE THERAPEUTICS, INC.
Unicycive Therapeutics
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California....
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE